ADAPTIVE BIOTECHNOLOGIES (ADPT) Stock Earnings & Estimates
NASDAQ:ADPT - US00650F1093 - Common Stock
13.18 USD
-0.13 (-0.98%)
13.18 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 185.3M 20.09% | 170.276M -8.11% | 178.957M 5.10% | 237.58M 32.76% | 275.15M 15.81% | 341.81M 24.23% | 379.44M 11.01% | |
| EBITDA YoY % growth | -177.7M 8.87% | -179.375M -0.94% | -136.088M 24.13% | -61.885M 54.53% | -28.049M 54.68% | 9.944M 135.45% | 112.2M 1,028.32% | |
| EBIT YoY % growth | -198.6M 4.98% | -201.606M -1.51% | -155.344M 22.95% | -128.293M 17.41% | -94.444M 26.38% | -51.425M 45.55% | 23.46M 145.62% | |
| Operating Margin | -107.18% | -118.40% | -86.81% | -54.00% | -34.32% | -15.04% | 6.18% | |
| EPS YoY % growth | -1.41 4.08% | -1.38 2.13% | -1.09 21.01% | -0.74 32.09% | -0.60 18.50% | -0.34 42.85% | 0.14 141.42% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 14.56% | -0.18 22.71% | -0.17 14.15% | -0.16 7.00% | -0.15 20.41% | -0.13 28.28% | -0.06 64.36% | -0.14 9.68% | -0.09 38.64% | -0.06 52.00% |
| Revenue Q2Q % growth | 60.112M 29.45% | 64.304M 35.49% | 61.205M 16.71% | 67.512M 14.66% | 69.62M 15.82% | 73.828M 14.81% | 73.95M 20.82% | 88.128M 30.54% | 80.886M 16.18% | 83.334M 12.88% |
| EBITDA Q2Q % growth | -10.132M 43.16% | -8.534M 41.47% | -6.018M 75.81% | -4.488M 71.60% | 5.273M 152.04% | -1.122M 86.85% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -29.753M 8.82% | -27.167M 19.71% | -25.858M 12.65% | -19.894M 20.54% | -19.692M 33.82% | -16.928M 37.69% | -8.16M 68.44% | -21.114M -6.13% | -13.362M 32.14% | -8.874M 47.58% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.17 45.16% | -0.24 | 0.07 | 30.19% |
| Q1 2025 Q2Q % growth | -0.20 39.39% | -0.30 | 0.10 | 32.96% |
| Q4 2024 Q2Q % growth | -0.23 23.33% | -0.26 | 0.03 | 12.00% |
| Q3 2024 Q2Q % growth | -0.22 37.14% | -0.29 | 0.07 | 24.98% |
| Q2 2024 Q2Q % growth | -0.31 6.06% | -0.34 | 0.03 | 8.94% |
| Q1 2024 Q2Q % growth | -0.33 17.50% | -0.35 | 0.02 | 5.24% |
| Q4 2023 Q2Q % growth | -0.30 -7.14% | -0.34 | 0.04 | 11.21% |
| Q3 2023 Q2Q % growth | -0.35 -9.37% | -0.35 | 0.00 | -1.25% |
| Q2 2023 Q2Q % growth | -0.33 10.81% | -0.35 | 0.02 | 6.66% |
| Q1 2023 Q2Q % growth | -0.40 9.09% | -0.38 | -0.02 | -4.08% |
| Q4 2022 Q2Q % growth | -0.28 34.88% | -0.35 | 0.07 | 20.75% |
| Q3 2022 Q2Q % growth | -0.32 20.00% | -0.38 | 0.06 | 16.56% |
| Q2 2022 Q2Q % growth | -0.37 -5.71% | -0.44 | 0.07 | 15.64% |
| Q1 2022 Q2Q % growth | -0.44 -51.72% | -0.47 | 0.03 | 5.93% |
| Q4 2021 Q2Q % growth | -0.43 -30.30% | -0.46 | 0.03 | 6.61% |
| Q3 2021 Q2Q % growth | -0.40 -48.15% | -0.43 | 0.03 | 6.91% |
| Q2 2021 Q2Q % growth | -0.35 -34.62% | -0.44 | 0.09 | 19.67% |
| Q1 2021 Q2Q % growth | -0.29 -16.00% | -0.42 | 0.13 | 30.41% |
| Q4 2020 Q2Q % growth | -0.33 -94.12% | -0.30 | -0.03 | -10.47% |
| Q3 2020 Q2Q % growth | -0.27 -145.45% | -0.29 | 0.02 | 6.89% |
| Q2 2020 Q2Q % growth | -0.26 78.86% | -0.29 | 0.03 | 10.56% |
| Q1 2020 Q2Q % growth | -0.25 | -0.21 | -0.04 | -19.85% |
| Q4 2019 Q2Q % growth | -0.17 | -0.20 | 0.03 | 15.82% |
| Q3 2019 Q2Q % growth | -0.11 | -0.24 | 0.13 | 54.43% |
| Q2 2019 Q2Q % growth | -1.23 | -0.14 | -1.09 | -787.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 58.879M 36.33% | 50.388M | 8.491M | 16.85% |
| Q1 2025 Q2Q % growth | 52.443M 25.24% | 43.532M | 8.911M | 20.47% |
| Q4 2024 Q2Q % growth | 47.459M 3.66% | 46.955M | 504K | 1.07% |
| Q3 2024 Q2Q % growth | 46.435M 22.46% | 41.012M | 5.423M | 13.22% |
| Q2 2024 Q2Q % growth | 43.19M -11.72% | 39.438M | 3.752M | 9.51% |
| Q1 2024 Q2Q % growth | 41.873M 11.23% | 39.56M | 2.313M | 5.85% |
| Q4 2023 Q2Q % growth | 45.784M -17.06% | 49.427M | -3.643M | -7.37% |
| Q3 2023 Q2Q % growth | 37.919M -20.72% | 43.822M | -5.903M | -13.47% |
| Q2 2023 Q2Q % growth | 48.926M 12.06% | 45.785M | 3.141M | 6.86% |
| Q1 2023 Q2Q % growth | 37.647M -2.52% | 37.547M | 100K | 0.27% |
| Q4 2022 Q2Q % growth | 55.2M 45.53% | 55.8M | -600K | -1.08% |
| Q3 2022 Q2Q % growth | 47.83M 21.18% | 48.991M | -1.161M | -2.37% |
| Q2 2022 Q2Q % growth | 43.66M 13.37% | 43.004M | 656K | 1.53% |
| Q1 2022 Q2Q % growth | 38.62M 0.47% | 38.464M | 156K | 0.41% |
| Q4 2021 Q2Q % growth | 37.93M 25.64% | 37.437M | 493K | 1.32% |
| Q3 2021 Q2Q % growth | 39.47M 50.08% | 37.368M | 2.102M | 5.63% |
| Q2 2021 Q2Q % growth | 38.51M 83.47% | 31.887M | 6.623M | 20.77% |
| Q1 2021 Q2Q % growth | 38.44M 83.84% | 28.302M | 10.138M | 35.82% |
| Q4 2020 Q2Q % growth | 30.19M 24.70% | 27.44M | 2.75M | 10.02% |
| Q3 2020 Q2Q % growth | 26.3M 0.92% | 24.055M | 2.245M | 9.33% |
| Q2 2020 Q2Q % growth | 20.99M -5.19% | 19.176M | 1.814M | 9.46% |
| Q1 2020 Q2Q % growth | 20.91M 65.04% | 21.958M | -1.048M | -4.77% |
| Q4 2019 Q2Q % growth | 24.21M | 22.14M | 2.07M | 9.35% |
| Q3 2019 Q2Q % growth | 26.06M | 22.53M | 3.53M | 15.67% |
| Q2 2019 Q2Q % growth | 22.14M | 19.696M | 2.444M | 12.41% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 12.76% | 11.72% | 14.5% | 13.22% |
| Revenue | 6.79% | 3.42% | 6.73% | 6.2% |